Funding Data Link References Status API Help
Page 1 of 2 results
Sort by: relevance publication year

A monoclonal antibody IMab-1 specifically recognizes IDH1R132H, the most common glioma-derived mutation

Journal Article published Dec 2009 in Biochemical and Biophysical Research Communications volume 390 issue 3 on pages 547 to 551

Research funded by NIH (5-P50-10876, 5-P50-NS-20023, CA11898, 5-R01-CA118822)

Authors: Yukinari Kato, Genglin Jin, Chien-Tsun Kuan, Roger E. McLendon, Hai Yan, Darell D. Bigner

Multicenter Phase 2 Trial of C is/Carboplatin, nAb -Paclitaxel, and C e TUX imab ( CACTUX ) as First-Line Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Journal Article published Apr 2018 in International Journal of Radiation Oncology*Biology*Physics volume 100 issue 5 on pages 1311 to 1312

Authors: D. Adkins, J. Ley, O. Atiq, C. Rigden, K. Trinkaus, T.M. Wildes, P. Oppelt